FTSE 100 storms higher after dovish Federal Reserve minutes

The FTSE 100 was in a buoyant mood on Thursday as the UK headed to the polls to vote in the general election.

However, the biggest driver of UK stocks on Thursday was not the prospect of Keir Starmer making a victory speech outside Downing Street tomorrow but the Federal Reserve minutes released last night.

“The FTSE 100 made a strong start on election day but its gains had far more to do with events on the other side of the Atlantic,” said AJ Bell investment director Russ Mould.

The Federal Reserve released minutes last night that suggested US monetary policy makers saw financial conditions easing to a point conducive to reducing borrowing costs.

“Participants highlighted a variety of factors that were likely to help contribute to continued disinflation in the period ahead,” the Federal Reserve wrote in their minutes.

“The factors included continued easing of demand–supply pressures in product and labor markets, lagged effects on wages and prices of past monetary policy tightening, the delayed response of measured shelter prices to rental market developments, or the prospect of additional supply-side improvements. The latter prospect included the possibility of a boost to productivity associated with businesses’ deployment of artificial intelligence–related technology.”

The mention of possible deflation as a result of AI is interesting for the long-term path of monetary policy and what it will do to US AI stocks when they reopen tomorrow.

US markets are closed for Independence Day today, so the true impact of The Fed’s dovishness on global markets may not be felt until tomorrow, by which time we will have received data from June’s Non-Farm Payrolls.

190,000 jobs are thought to have been created last month. Should the headline figure miss estimates, the case for a rate cut becomes much stronger. In such a scenario, one would expect a sharp rally in stocks.

FTSE movers

Gains were broad on Thursday, with 83 of the FTSE 100 constituents trading higher at the time of writing.

UK housebuilders were well bid as traders positioned for a Labour victory and the promise of planning reforms and a boom in housebuilding.

Smith & Nephew was the FTSE 100’s top riser on Thursday after activist investor Cevian Capital took a 5% stake in the firm. The Smith & Nephew share price has had a dismal run, and investors will hope the activist shakes the firm up. Shares were 9% higher at the time of writing.

Next was the biggest faller as the retailer traded ex-dividend.

AIM movers: Image Scan contract and DF Capital forecast upgrade

3

X-ray imaging technology developer Image Scan (LON: IGE) has won a £3m contract to supply ThreatScan portable x-ray systems to NP Aerospace for bomb technicians. There will be a three-month trial process before the contract commences in September. That means that £1m is expected to be recognised in the year to September 2025. Forecast revenues for 2024-25 are £3.5m. The share price soared 62.3% to 2.15p.

Finance provider DF Capital (LON: DFCH) increased new loan obligations by 17% in the first half. Interim pre-tax profit is expected to be £9m, including £1.7m of recoveries on RoyaleLife, and this has led Panmure Liberum to raise its full year pre-tax profit forecast by 55% to £14m. Arrears on the loan book are reducing. The share price improved 24.1% to 33.5p.

Retail software and systems supplier itim (LON: ITIM) has secured a five-year, multi-million pound contract with Assai Atacadista, which has 300 stores in Brazil. The software will help with price optimisation and promotion. This helps underpin 2024 forecast revenues of £17m and EBITDA of £1m. The share price increased 15.2% to 38p.

Fire suppression technology developer Zenova Group (LON: ZED) says Zenova FX fluid has been independently tested by external laboratories. This shows that the range of fire extinguishers conforms to current and planned regulations. This means that they will still be legal to use in the EU after the beginning of July 2025. The share price rose 7.41% to 1.45p.

Fusion Antibodies (LON: FAB) reports a positive first quarter of the year to March 2025. Revenues jumped from £241,000 to £522,000. The order book is worth £700,000. This should all be recognised this year. Last year’s revenues were £1.14m. The share price is 5% ahead at 3.15p.

FALLERS

Medical monitoring equipment developer Deltex Medical Group (LON: DEMG) says interim revenues were flat at £1.06m with orders worth £92,000 awaiting components or payment. The improvement in EBITDA should continue in the second half following a reduction in employees. There was cash of £325,000 at the end of June. The new TrueView system is eligible to purchase via a NHS Supply national framework. The share price slipped 9.09% to 0.15p.

In the six months to May 2024, Light Science Technologies (LON: LST) revenues improved from £4.4m to £5.2m and gross margins increased. There should be a positive EBITDA in the first half. Management has increased its borrowing facility. The committed forward order book is worth £4.7m, including £935,000 for the new fire protection business. The share price fell 3.51% to 2.75p.

Graeme Coulthard increased his stake in TheWorks.co.uk (LON: WRKS) from 6.48% to 7.15%. Even so, the share price declined 2.86% to 23.75p.

Ex-dividends

Facilities by ADF (LON: ADF) is paying a final dividend of 0.9p/share and the share price declined 0.5p to 53.5p.

Next 15 Group (LON: NFG) is paying a final dividend of 10.6p/share and the share price slipped 7.5p to 778.5p.

Polar Capital (LON: POLR) is paying a final dividend of 32p/share and the share price fell 25p to 570p.

Premier Miton (LON: PMI) is paying an interim dividend of 3p/share and the share price dipped 1.5p to 70p.

Skillcast (LON: SKL) is paying a final dividend of 0.28p/share and the share price is unchanged at 38.5p.

Union Jack Oil (LON: UJO) is paying a final dividend of 0.25p/share and the share price fell 0.25p to 15.5p.

Young & Co’s Brewery (LON: YNGA) is paying a final dividend of 10.88p/share and the share price fell 1p to 965p.

NewRiver REIT acquires Ellandi Management in strategic expansion move

NewRiver REIT has announced the acquisition of Ellandi Management Limited, a UK-based asset and development management firm specialising in retail and regeneration projects.

NewRiver REIT shares were down 3.5% at the time of writing.

Ellandi brings to the table a portfolio of 16 shopping centre asset management mandates, covering over 6.3 million square feet, with 10 different partners.

In the financial year ending 30 April 2024, Ellandi reported fee income of £5.7 million and EBITDA of £1.1 million.

NewRiver has agreed to an initial cash payment of £5 million for the acquisition, with potential additional payments of up to £4 million tied to EBITDA performance over a three-year period. Given the market reaction, investors aren’t overly enthralled with the terms.

NewRiver’s combined Capital Partnership business will now manage assets worth approximately £1.5 billion, encompassing 21 shopping centres and 18 retail parks across 13 partners.

When including NewRiver’s wholly-owned retail assets, the total Assets Under Management (AUM) rises to about £2.0 billion, spanning 44 shopping centres and 29 retail parks. This expanded portfolio is expected to generate an existing fee income stream of £8.2 million.

India’s post-election reckoning 

James Thom, Investment Manager, abrdn New India Investment Trust plc 

  • An unexpected election result saw Modi’s BJP lose its majority. 
  • The result has created volatility but is unlikely to derail the economic growth trajectory in India. 
  • India still has a significant pathway of growth. 

Indian stock markets have regained some equilibrium after the shock of the General Election result. After some initial volatility, investors are starting to take a more sober look at the impact of Premier Modi’s stumble in the polls and whether it will impact economic reform.  

An unexpected election result saw Modi’s BJP lose its majority. It must now govern in coalition. However, it is unlikely that the election result will substantially derail the economic growth trajectory in India. Modi’s party still has the largest number of seats in parliament – 240. The next largest party – the Indian National Congress – has just 99. It may force Modi to water down some of its ambitions, particularly over land reform and labour reform, but there is likely to be broad continuity.  

India still has a significant pathway of growth. GDP per capita is just $2,730. This compares to $13,140 for China or $11,350 for Brazil. On current growth rates, it could become the world’s third largest economy by the end of the decade. The government has set the goal of becoming a ‘developed country’ by 2047. Although definitions vary, this would suggest a GDP per capita of over $20,000 and would imply sustained and significant growth for India. The IMF projects growth of over 6.5% for the next three years and the recent election does little to disrupt that.  

There are a range of factors supporting Indian growth over and above government initiatives. For example, India is a clear beneficiary of the ‘China plus one’ phenomenon, which has seen global manufacturing companies diversify their production away from China. The government has played a role, putting incentives in place, but the trend is self-sustaining. There has already been significant success in smart phones with Apple setting up in India, but similar growth has been seen for washing machines, renewable energy components and the food industry.  

Fragilities 

Nevertheless, the volatility surrounding the election does expose some fragility in the Indian market. Although it has recovered, it became clear there was a ‘Modi premium’ in some of the state-owned companies and in some family-owned businesses tied to the government agenda. While these businesses may continue to thrive, we prefer not to invest where growth is wholly dependent on the state.   

It also shows why investors need to show some caution on valuations. The market is expensive relative to its emerging market peers and is a little above its own long-term average. It has always traded at a premium, given the growth prospects and strong governance of its companies, but some parts of the market are particularly highly valued.  

We believe it is important to focus on those companies where there is momentum for growth and visibility on earnings. We see plenty of companies still beating expectations on earnings and this provides comfort that companies can ‘grow into’ their valuations. The abrdn New India Investment Trust focuses on six structural themes that, in our view, have momentum independent from the government agenda.  

‘Aspirational consumption’, for example, is supported by rising GDP per capita. As the economy grows, the middle classes thrive and demand more goods and services. There is also a ‘premiumisation’ trend, as they move to higher quality options. Phoenix Mills is India’s leading premium shopping mall operator, which is benefiting from a first-mover advantage as the Indian consumer discovers the mall experience.  

Demand for better healthcare services also increases as wealth rises. We have several hospital and pharmaceutical companies in the portfolio supported by this trend. We have a ‘building India’ theme, which incorporates infrastructure development and urbanisation. Some of this is dependent on government policy but is likely to happen under governments of any kind. Urbanisation is a feature of any fast-growing economy and India is no exception.  

We’ve bought in to the real estate sector, for example, which is in the early stages of a longer-term recovery. There are also second-order beneficiaries of the housing boom. We bought Pidilight, for example, which makes wood adhesive and is a significant beneficiary of the demand for furniture.  

Digitalisation is also a powerful trend. The country has developed a Digital Public Infrastructure network, commonly referred to as the ‘India Stack’. This unique initiative is designed to help citizens access their data and information online and for government and businesses to provide targeted digital services to India’s vast population underpinned by thumbprint authentication technology. 

India continues to suffer from chronic power deficits. In May, the government said it was expecting the country’s biggest power shortfall for June in 14 years. Solar PV and onshore wind deployment is expected to double in India by 2028, which is also creating a range of investment opportunities.  

On the abrdn New India Investment Trust, we continue to find plenty of good ideas and have initiated plenty of new positions this year. The recent turmoil around the election does not derail the Indian growth story, but it has exposed some sectors where valuations had become extended. We avoid those areas with a ‘Modi premium’ and look for companies with self-sustaining momentum. There are plenty to be found, regardless of where power lies. 

Companies selected for illustrative purposes only to demonstrate the investment management style described herein and not as an investment recommendation or indication of future performance. 

Important information  

Risk factors you should consider prior to investing:  

  • The value of investments, and the income from them, can go down as well as up and investors may get back less than the amount invested.  
  • Past performance is not a guide to future results.  
  • Investment in the Company may not be appropriate for investors who plan to withdraw their money within 5 years.  
  • The Company may borrow to finance further investment (gearing). The use of gearing is likely to lead to volatility in the Net Asset Value (NAV) meaning that any movement in the value of the company’s assets will result in a magnified movement in the NAV.  
  • The Company may accumulate investment positions which represent more than normal trading volumes which may make it difficult to realise investments and may lead to volatility in the market price of the Company’s shares.  
  • The Company may charge expenses to capital which may erode the capital value of the investment.  
  • Movements in exchange rates will impact on both the level of income received and the capital value of your investment.  
  • There is no guarantee that the market price of the Company’s shares will fully reflect their underlying Net Asset Value.  
  • As with all stock exchange investments the value of the Company’s shares purchased will immediately fall by the difference between the buying and selling prices, the bid-offer spread. If trading volumes fall, the bid-offer spread can widen.  
  • The Company invests in emerging markets which tend to be more volatile than mature markets and the value of your investment could move sharply up or down. 
  • Yields are estimated figures and may fluctuate, there are no guarantees that future dividends will match or exceed historic dividends and certain investors may be subject to further tax on dividends. 

Other important information: 

Issued by abrdn Fund Managers Limited, registered in England and Wales (740118) at 280 Bishopsgate, London EC2M 4AG, authorised and regulated by the Financial Conduct Authority in the UK. 

Find out more at www.abrdnnewindia.co.uk or by registering for updates. You can also follow us on social media: X and LinkedIn

Booming manufacturing, surging trade, and record highs with Vietnam Holding

The UK Investor Magazine was delighted to welcome Craig Martin, Chairman of Dynam Capital and fund manager of Vietnam Holding, back to the podcast for a fascinating discussion about the Vietnamese economy and the trust’s portfolio.

Explore Vietnam Holding in the UK Investor Magazine Investment Centre

At the time of recording, Vietnam Holding shares were just a whisker away from a record high which was set just a few days prior.

We discuss the key economic data behind Vietnamese equities’ ascendancy and the positioning AAA-rated managers at Dynam Capital have taken to drive significant outperformance compared to the benchmark.

Craig provides an overview of Vietnam Holding’s high-conviction portfolio detailing specific companies and core investment themes.

Angle – Will Cancer Care Liquid Biopsy Developers Give Its Shareholders Any Good AGM News Next Thursday?

In early May this group’s shares were trading at 25p each.

However, since its success in raising £9.3m of fresh funds just three weeks ago, the shares of Angle Plc (LON:AGL) have been continuing to trade below the discounted share issue at 15p each, falling to an after fund-raise low of 13.50p last week.

So, investors must be hoping that the company could be giving out some good news at its midday AGM at the Surrey Technology Centre in Guildford next Thursday (11th July).

The Business

The company is a world-leading liquid biopsy company with innovative circulating tumour cell solutions for use in research, drug development and clinical oncology using a simple blood sample.

The company’s FDA-cleared and patent protected circulating tumour cell harvesting technology, known as the Parsortix® PC1 system, enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.

The Parsortix technology is a unique CTC harvesting method using patented microfluidics in the form of a single use cassette, housed within an automated system.

It captures and harvests live, intact circulating tumour cells and CTC clusters from whole blood for downstream analysis.

Management Comment

Just over a month ago when ANGLE announced its 2023 results, Chief Executive, Andrew Newland, stated that:

“ANGLE has made considerable commercial progress in 2023 through the ongoing execution of our strategy. Major efforts have been focused on both the products and services commercialisation channels and on the development of “content” to provide applications of the Parsortix system for customers.

This has resulted in the launch of four imaging assays, a strategic partnership with BioView for the development of a quantitative HER2 assay kit, repeat and new business with pharmaceutical customers for services and positive research study results for the Company’s comprehensive solution for dual molecular analysis of CTC-DNA and ctDNA from a single blood sample.

2023 also saw the first product sales from our newly established global distribution network and we are optimistic about the growth in global sales of the Parsortix system, consumables, and assay kits during the current financial year. 

I am delighted that 2024 has started strongly with three new contracts with two large pharma customers and we look forward to continuing this commercial momentum in the year ahead.”

My View

It is stated that the Parsortix technology has the potential to deliver profound improvements in clinical and health economic outcomes in the diagnosis and treatment of cancer – if that is so then the £43m valued company’s own potential could be absolutely massive.

It is still at a very early stage in the development of the company and its shares are only for risk-tolerant investors – even so at around the current 14p they could prove to be a worthwhile gamble.

FTSE 100 surges higher on interest rate hopes, JD Sports sinks

Interest rate hopes are back! After a couple of weeks of malaise following Federal Reserve and Bank of England decisions to keep interest rates on hold, a speech by Fed Chair Jerome Powell has once more ignited hopes of rate cuts later this year.

Equity bulls jumped on the Chair’s comment and sent the S&P 500 to record highs in the US overnight. UK traders didn’t need asking twice to bid up the FTSE 100, which was trading 0.5% higher at the time of writing.

“The FTSE 100 has opened higher, riding on the coattails of the fresh enthusiasm which swept over Wall Street, with any political uncertainty pushed into the background,” said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

“Stocks have largely been driven upwards by hopes that interest rate cuts are on the horizon and a soft landing is in sight, thanks to encouraging comments from the chair of the Federal Reserve.

“Jerome Powell said that the US is back on a disinflationary path due to recent weaker inflation readings.  He stressed that policymakers are wary of keeping monetary policy ‘too tight for too long’ and losing expansion in the economy.”

Macroeconomics could well help propel stocks higher through the rest of the week with Fed minutes due out this evening and June Non-Farm Payrolls set for release on Friday.

The FTSE 100’s gains were broad on Wednesday, with 85 constituents trading higher at the time of writing. Cyclical sectors enjoyed buying pressure as risk appetite grew.

IAG was the top riser, gaining 4%, closely followed by Fresnillo who was helped higher by a bid in gold and silver.

Precious metal prices slipped after recent central bank meetings suggested the market would have to wait for rate cuts – prices showed signs of reversing on Wednesday with a potential interest rate cut on the horizon.

JD Sports was the biggest faller after Barclays cut the stock to underweight with a 110p price target. The downgrade follows poor results from Nike, the brand that accounts for around 50% of JD Sports sales.

Vodafone and Virgin Media O2 announce network sharing agreement 

Vodafone UK and Virgin Media O2 have struck a new, long-term network sharing agreement that could significantly reshape the UK mobile market.

The deal, which extends their existing partnership for more than a decade, aims to bolster mobile coverage and improve services for customers across the country.

The agreement hinges on the approval of Vodafone UK’s merger with Three UK by the Competition and Markets Authority (CMA). If given the green light, the newly formed entity has committed to an £11 billion network investment plan over the next decade. This massive injection of capital is expected to drive revenue growth and potentially boost profitability.

Virgin Media O2 has pledged £2 billion annually for its networks and services. This dual investment strategy is poised to enhance the quality of mobile connectivity, potentially leading to increased customer satisfaction and reduced churn rates – key factors in maintaining and growing revenue streams.

“With this agreement and our merger with Three, we will transform the mobile experience for over 50 million customers in the UK for the long-term, providing significant network improvements including more choice, better quality and greater coverage across the country,” said Ahmed Essam, CEO, European Markets, Vodafone.

“These benefits extend to both retail and wholesale MVNO customers. The proposed merger, together with this agreement, will boost competition by establishing a strong third player in the UK mobile market and will improve the balance of spectrum holdings, levelling the playing field between the UK’s mobile operators.”

Keywords Studios set for £2.1 Billion takeover

Keywords Studios has agreed to a cash acquisition valued at £2.1 billion, or 2,450p per share, by a newly formed entity backed by private equity firm EQT, CPP Investments, and Rosa Investments.

The offer price represents a 66.7% premium to the closing price on 17 May 2024, the last business day before the offer period began.

The company is the latest London-listed company to be swooped on by private equity firms who see deep value in high-quality shares that aren’t appreciated by public markets.

From a valuation perspective, the deal implies an enterprise value of approximately £2.2 billion. This translates to a multiple of 15.9 times Keywords Studios’ adjusted EBITDA for the year ended 31 December 2023, which stood at £139 million.

The acquisition is structured to be financed through a combination of equity capital from the consortium members and debt financing.

Notably, the offer price is declared as final, with the bidders reserving the right to increase it only under specific circumstances, such as a competing offer emerging.

The Keywords Studios board has unanimously recommended that shareholders vote in favour of the scheme.

AIM movers: Arkle Resources drilling plans and discounted Physiomics placing

1

Arkle Resources (LON: ARK) says its partner Group Eleven Resources Corp has announced plans to drill three or four holes Stonepark zinc project in Ireland, where Arkle has a 23.4% interest. This should start in the third quarter. The costs are fully funded. The share price jumped 37.5% to 0.275p.

Brain tumour treatment developer CRISM Therapeutics Corporation (LON: CRTX) has been hit by a declining share price since joining AIM via the reverse takeover of Amur Minerals Corporation at the end of May. The opening share price was 24p and it had fallen by nearly three-quarters. Non-executive director Gerry Beaney bought 25,000 shares at 9.25p each. CRISM has developed ChemoSeed, which is a treatment for glioblastoma and high-grade glioma, which are brain tumours where there is no current cure. It is an implantable, bioresorbable drug delivery platform. The share price recovered 24% to 7.75p.

ECR Minerals (LON: ECR) has submitted 44 samples from Bailieston in Australia for testing and 12 have returned results greater than 0.1% antimony. Increasing demand for the mineral led to the reanalysing of past samples and the project is near to existing resources. The antimony price has reached record levels. The share price is 22.8% higher at 0.35p.

Market research services provider System1 Group (LON: SYS1) is reinstating its dividend following a strong recovery in pre-tax profit from £600,000 to £3.1m. Canaccord Genuity has upgraded its pre-tax profit forecast for this year from £4m to £4.4m. This is on the back of strong trading in the US. The share price rose 17.3% 610p and it has more than doubled this year.

Aptamer Group (LON: APTA) has signed an agreement with AstraZeneca to evaluate Optimer fibrotic liver delivery vehicles for the targeted delivery of siRNA provided by AstraZeneca. Optimer technology could enable targeted delivery and development of compounds that have advantages over cell and tissue-targeting methods. The share price is 8% ahead at 0.675p, having been as high as 0.75p..

FALLERS

Pharma mathematical modelling services provider Physiomics (LON: PYC) has raised £381,000 at 0.6p/share, which is 50% of the previous market price. A WRAP retail offer could raise up to £25,000. It closes at 4.30pm on 4 July. In June 2023, £380,000 was raised at 1p/share. The cash will finance the recruitment of a head of mathematical modelling service line and investment in marketing. It also wants to build a biostatics capability and implement a personalised dosing tool on the DoseMeRx platform. The share price slumped 43.8% to 0.675p.

Pubs and bars operator Nightcap (LON: NGHT) shares continue to decline ahead of its departure from AIM. Robus Capital Management has been mopping up shares and holds 14.3%. The share price slipped a further 12.3% to 2.85p.

Energy and water efficiency services provider Eneraqua Technologies (LON: ETP) says there has been a deferral of contracts due to the General Election. This means there is likely to be a greater second half weighting. A return to profit is anticipated for the second half and for the year as a whole. The share price fell 9% to 45.5p.

Machine learning technology company Insig AI (LON: INSG) has extended the redemption date of convertible loan notes has been extended to the end of September 2025. The annual interest rate on the £1m of convertibles held by chief executive Richard Bernstein will reduce from 8% to 6%. The interest rate on the £500,000 held by David Kyte remains at 12%. The share price is 7.14% lower at 16.25p.